Target intelligence / Profile preview

Biophysical properties of white blood cell

Molecular classification
Other
01

Overview

The term "Biophysical properties of white blood cells" refers to the measurable physical and mechanical characteristics of leukocytes—including size, shape, elasticity/deformability, motility/locomotion patterns, and responses to external stimuli. These properties are not a single molecular target or receptor but rather a set of cellular features that can be quantified using techniques such as flow cytometry or microfluidic assays[1][3][5]. For example: > "Granulocytes from patients with sepsis possessed an increased deformability... compared with control subjects without sepsis... granulocyte deformability proved to be the most useful metric in distinguishing between patients with sepsis and healthy donors"[3]. These biophysical parameters are used in research and clinical diagnostics for disease states such as infections (e.g., sepsis), cancer (e.g., leukemia), autoimmune disorders, and other conditions affecting immune function[6][8]. They may serve as **functional biomarkers**—for instance, increased granulocyte deformability is associated with sepsis[3], while abnormal counts or motility patterns can indicate infection or hematologic malignancy[5][8]. However, **this entry is not a therapeutic target** like a receptor or enzyme; it describes general cellular attributes rather than a discrete molecule suitable for drug targeting. Therefore: * The entry is considered incorrect as a "target" in the conventional sense. * There are no specific drugs that interact directly with these biophysical properties; instead, therapies may affect white blood cells more broadly by altering their numbers or functions through indirect mechanisms such as chemotherapy or immunotherapy[4][6]. * No canonical abbreviation exists. In summary: "Biophysical properties of white blood cells" describes quantifiable physical traits relevant for diagnostics and research but does not represent an actionable molecular target for drug development.

Other names
White blood cell biophysical characteristicsLeukocyte mechanical propertiesWBC deformabilityLeukocyte physical traits
02

Biological functions

Immune responseCell migrationInflammationHost defense
03

Disease associations

InfectionSepsisCancer (as part of tumor microenvironment)Autoimmune disease
04

Biomarkers

Granulocyte deformability (for sepsis diagnosis)[3]White blood cell count (for infection, leukemia monitoring)[8]

Beyond the preview

Go deeper on Biophysical properties of white blood cell.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biophysical properties of white blood cell.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call